Pulmatrix
PULM
$1.95
Share price
2.63%
Change (1 day)
-27.24%
Change (1 year)
Categories
Pulmatrix (PULM) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $11.37 M
According to Pulmatrix's latest financial reports the company's total liabilities are $11.37 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Pulmatrix - Total liabilities on balance sheet (from 2013 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $9.84 M | -13.41% |
| 2021-12-31 | $11.36 M | -23.99% |
| 2020-12-31 | $14.95 M | -40.36% |
| 2019-12-31 | $25.07 M | 771.1% |
| 2018-12-31 | $2.87 M | -50.71% |
| 2017-12-31 | $5.84 M | -26.08% |
| 2016-12-31 | $7.9 M | -35.58% |
| 2015-12-31 | $12.26 M | |
| 2015-03-31 | $0.63 M | -32.95% |
| 2014-03-31 | $0.94 M | 837.62% |
| 2013-03-31 | $0.1 M | |
| 2012-03-31 | $N/A |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pieris Pharmaceuticals PIRS | $7.53 M | -33.76% | 🇺🇸 USA |
 OPKO Health
OPK | $0.72 B | 6,241.41% | 🇺🇸 USA |
 Blueprint Medicines
BPMC | $0.72 B | 6,299.26% | 🇺🇸 USA |